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Abstract The study aims were to compare two models (The
Pediatric Risk of Mortality III (PRISM III) and Pediatric Lo-
gistic Organ Dysfunction (PELOD-2)) for prediction of mor-
tality in a pediatric intensive care unit (PICU) and recalibrate
PELOD-2 in a Portuguese population. To achieve the previous
goal, a prospective cohort study to evaluate score performance
(standardized mortality ratio, discrimination, and calibration)
for both models was performed. A total of 556 patients con-
secutively admitted to our PICU between January 2011 and
December 2012 were included in the analysis. The median
age was 65 months, with an interquartile range of 1 month
to 17 years. The male-to-female ratio was 1.5. The median
length of PICU stay was 3 days. The overall predicted number
of deaths using PRISM III score was 30.8 patients whereas
that by PELOD-2 was 22.1 patients. The observed mortality
was 29 patients. The area under the receiver operating charac-
teristics curve for the two models was 0.92 and 0.94, respec-
tively. The Hosmer and Lemeshow goodness-of-fit test
showed a good calibration only for PRISM III (PRISM III:
χ2=3.820, p=0.282; PELOD-2: χ2=9.576, p=0.022).
Conclusions: Both scores had good discrimination.
PELOD-2 needs recalibration to be a better reliable prediction
tool.
What is Known:
• PRISM III (Pediatric Risk of Mortality III) and PELOD (Pediatric
Logistic Organ Dysfunction) scores are frequently used to assess the
performance of intensive care units and also for mortality prediction in
the pediatric population.
• Pediatric Logistic Organ Dysfunction 2 is the newer version of PELOD
and has recently been validated with good discrimination and
calibration.
What is New:
• In our population, both scores had good discrimination.
• PELOD-2 needs recalibration to be a better reliable prediction tool.
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Abbreviations
GCS Glasgow Coma Scale
PaO2/FiO2 ratio Partial pressure of arterial oxygen/
fraction of inspired oxygen ratio
PaCo2 Partial press ure of arterial carbon dioxide
PELOD Pediatric Logistic Organ Dysfunction
PICU Pediatric intensive care unit
PPV Positive predictive value
PRISM III Pediatric Risk of Mortality III
PT Prothrombin time
ROC Receiver operator characteristic
SMR Standardized mortality rate
Introduction
Mortality reduction is an important aim of a pediatric intensive
care unit (PICU). Risk-adjustment tools that predict death in
PICUs are a rational and objective way to quantify severity
and have become established in the past 20 years [3].
Diverse scoring systems have been developed for all age
groups including pediatric [22, 26]. Mortality is the most fre-
quently assessed outcome. These scores have been developed
not to predict the outcome of individual patient, but as tools
for assessing the performance of intensive care units relative
to other units, to outcome measure, and/or to enrollment
criteria in clinical trials. Pediatric Risk of Mortality III
(PRISM III) and Pediatric Logistic Organ Dysfunction
(PELOD) scores are frequently used for mortality prediction
in the pediatric population [2, 11, 13, 20, 28]. PELOD-2 is the
newer version of PELOD and has recently been validated with
good discrimination and calibration [14].
To make use of these scores, it is important to know if the
score is relevant and valid in a patient population, which is
different from the population in whom it was derived. There
are very few published studies which evaluated the performance
of severity of illness scoring systems in Portuguese PICUS [17,
18]. PELOD-2 performance has not been estimated in Portugal.
The objectives of this study were to evaluate the perfor-
mance of the PRISM III and PELOD-2 scores, investigating
the relationship between observed outcomes (death/survival),
the mortality and survival rates in children admitted in PICU;
to determine the suitability of each score for monitoring the
quality of intensive care in our unit; and to recalibrate
PELOD-2 in our population.
Materials and methods
A cohort study was conducted in a Portuguese PICU. Several
data were collected prospectively for PRISM III estimation.
Using these data, PELOD-2 estimation was also possible. All
patients (1 month to 18 years old) requiring PICU admission
over a period of 24 months from January 2011 to December
2012 were included in this study.
Patients with a PICU stay less or dying within the first 8 h
of admission, younger than 1 month or older than 18 years
old, those transferred to other PICUs, and those with missing
information on variables used to estimate the PRISM III and
PELOD-2 scores were excluded from the study. Patients who
left against medical advice were excluded from the study as
the outcome was not known.
Age, gender, diagnosis at the time of PICU admission,
post-surgical care and mechanical ventilation requirements,
length of PICU stay, and outcome (survived/death) were re-
corded on a data collection form devised for the study.
For the PRISM III score, several variables (namely systolic
and diastolic blood pressures, heart rate, respiratory rate,
PaO2/FiO2 ratio (partial pressure of arterial oxygen/fraction
of inspired oxygen ratio), PaCo2 (partial pressure of arterial
carbon dioxide), Glasgow Coma Scale (GCS), pupillary reac-
tion, PT (prothrombin time), ratio (test/control), total bilirubin,
serum potassium, serum calcium, blood glucose, and serum
bicarbonate) were collected at 24 h of PICU admission. Data
collected was entered in Pediatric Intensive Care Unit Evalu-
ations Software–PRISM III program (PICUEs version 3.2.4).
Details of the components of PRISM III can be found in Pol-
lack et al.’s paper [20].
For the PELOD-2 score, five organ systems (neurologic,
cardiovascular, respiratory, renal, and hematologic) are con-
sidered and 10 variables (namely GCS, pupillary reaction,
lactatemia, mean arterial blood pressures, PaO2/FiO2 ratio,
PaCo2, invasive ventilation, creatinine, white blood cell
count, and platelets) were collected at 24 h of PICU admis-
sion. If a variable was measured more than once in 24 h, the
worst value was used in calculating the score. Details of the
components of PELOD-2 score, together with the coefficients
allowing calculation of mortality risk, are given elsewhere
[14]. This study was reviewed by the local institutional review
board and is exempt from requiring approval.
Statistical analysis
Descriptive analysis was utilized for sample characterization
(mean, median, standard deviation). The distribution of vari-
ables was tested by the Kolmogorov–Smirnov test. Mann–
Whitney test was used to compare two or more independent
samples, according to variables’ distribution.
Comparison of the general similarity between observed
mortality and that estimated by the standardized mortality rate
(SMR) was calculated [6]. The SMR is the ratio of risk adjust-
ed, observed mortality to the expected mortality derived from
the development set. If the 95 % confidence intervals (95 %
CI) around the SMR are less than 1.0, then mortality is lower
than that seen in the development set; conversely, confidence
intervals greater than 1.0 signify a higher mortality. If the 95%
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confidence interval of the SMR includes the value 1.0, the
observed number of deaths is not significantly different than
the expected number of deaths.
The capacity of PRISM III and PELOD-2 scores for dis-
crimination between survived and expired patients (capacity
of discrimination) was calculated by receiver operator charac-
teristics (ROC) curve [24]. Acceptable discrimination is rep-
resented by an area under the curve of 0.70–0.79, good dis-
crimination by an area ≥0.80, and excellent discrimination by
an area ≥0.90 [8].
For scores’ aptness, the Hosmer–Lemeshow goodness-of-fit
test was employed to test the agreement between observed and
predicted risks of death within quintiles of risk score (calibra-
tion). Calibration signifies how well the test predicts both mor-
tality and survival across subcategories of risk. Acceptable cal-
ibration is evidenced by a p value ≥0.05 [10]. Otherwise, the
model score has no justification to be applied in that population.
In this case, to recalibrate the model, an adjustment of the
intercept and the regression coefficient using the calibration
intercept (λb) and calibration slope (βb) must be performed [9].
To estimate the magnitude of the association between each
score and mortality occurrence, odds ratios (OR) and the re-
spective 95 % confidence intervals were calculated using un-
conditional logistic regression. Two different models were
considered: crude model (model 1) and model 2 adjusting
for age, sex, category of illness on admission, post-surgical
care, mechanical ventilation required, and length of stay in
PICU. Considering that PRISM III and PELOD-2 scores do
not share a common scale, the authors have standardized the
scores to have a common mean of zero and a standard devia-
tion of one (that is, convert them to z-scores). Such standard-
ization would enable to describe impact estimates as effect
sizes, which facilitate the comparison or aggregation of impact
estimates based on distinct assessments. For scores not cali-
brated to our population, to improve its performance, a recal-
ibration was performed by using new data.
Data was analyzed using Statistical Program for Social Sci-
ence version 22.0 (SPSS Inc, Chicago, IL, USA, 2013). The
significance level was set at 5 %.
Results
Out of 589 critically ill children consecutively admitted to PICU,
33 were excluded due to exclusion criteria previously described
(one death in the first 8 h after PICU admission). Thus, the final
sample included 556 patients (331 boys and 225 girls).
Participant’s characteristics are described in Table 1. The me-
dian age of the patients was 65 months (IQR 1–214). A median
of 5 points was observed for each score. Disease categories
included infection (4.7 %), respiratory (16.9 %), cardiovascular
(23.9 %), neurological (14.9 %), cancer (12.1 %), and trauma
(12.9 %). Sixty-nine percent of patients were mechanically
ventilated. The median length of PICU stay was 3 days (IQR
0–155), and the crude mortality was 5.2 % (29/556).
Total PRISM III and PELOD-2 scores were significantly
higher in patients having outcome as death, and in that order,
they predicted 30.76 (5.5 %) and 22.14 (4.0 %) deaths
(Tables 2 and 3). The positive predictive value (PPV) for pa-
tient’s mortality highest risk (5th quintile) was 22 % for PRIS
Table 1 Characteristics of 556 critically ill children admitted to PICU
Characteristic Number (%) of patientsa
Age, months, median (IQR) 65 (1–214)
Age group
1 month–<1 year (infants) 111 (20.0)
1 year–<12 years (children) 302 (54.3)
≥12 years (adolescents) 143 (25.7)
Male/female ratio 1.5
Surgical patients 301 (54.1)
Mechanical ventilation required 381 (68.5)
PRISM III
Mean (SD) 6.3 (6.0)
Median (IQR) 5 (0–46)
PELOD-2
Mean (SD) 5.1 (3.1)
Median (IQR) 5 (0–18)
Category of illness on admission
Infection 26 (4.7)
Respiratory 94 (16.9)
Cardiovascular 133 (23.9)
Neurological 83 (14.9)
Cancer 67 (12.1)
Trauma 72 (12.9)
Other 81 (14.6)
Number who died in PICU 29 (5.2)
Length of stay in PICU, d, median (IQR) 3 (0–155)
IQ interquartile interval, SD standard deviation, PRISM III Pediatric Risk
of Mortality III, PELOD 2 Pediatric Logistic Organ Dysfunction 2
aUnless stated otherwise
Table 2 PRISM III and PELOD-2 scores among critically ill children
admitted to PICU
Score Patients
Nonsurvivors Survivors
Mean (SD) Median (IQR) Mean (SD) Median (IQR)
PRISM III 19.7* (9.8) 18 (5–46) 5.6 (4.7) 5 (0–26)
PELOD-2 11.4* (3.5) 12 (6–18) 4.8 (2.6) 5 (0–12)
IQ interquartile interval, PRISM III Pediatric Risk of Mortality III,
PELOD 2 Pediatric Logistic Organ Dysfunction 2
*p<0.001, Mann–Whitney test (survivors vs. nonsurvivors)
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M III and 24 % for PELOD-2 (Table 3). The 22 patients who
have died and been identified in the 5th quintile by PELOD-2
are also identified in the 5th quintile by PRISM III.
The prognostic scoring systems performances are showed in
Table 4. TheHosmer and Lemeshowgoodness of fit test showed
a good calibration for PRISM III score (χ2=3.820, p=0.282).
Overall, the PELOD-2 underestimated the risk of death.
Goodness-of-fit chi-square test demonstrated statistically lack
of fit (χ2=9.576, p=0.022) (Table 4). PELOD-2 recalibrations
using the calibration intercept λb and calibration slope βb result-
ed in good fit and adequate prediction of risk of death. The
recalibrated model is represented by the equation: logit(-
mortality)=−15,17+0,34xPELOD−2 (χ2=3.820, p=0.282).
Nonetheless, PELOD-2 showed better discrimination using
area under ROC (AUC=0.94 (0.90–0.98)) than PRISM III
(AUC=0.92 (0.86–0.97)). This is confirmed by the logistic
regression models (Table 5). After adjustment for several var-
iables including age, sex, category of illness on admission,
post-surgical care, mechanical ventilation required, and length
of stay in PICU, each 1 unit (z-score) increase in PRISM III
and PELOD-2 was associated with a 6.2- (OR 6.2 [95 % CI
3.4–11.3]) and 10-fold (OR 10.0 [95 % CI 4.8–20.8]) in-
creased risk of death, respectively.
Discussion
In this study, we compared PRISM III and PELOD-2 perfor-
mance evaluating the calibration and discrimination for both
scores. Calibration ismore important while comparing expect-
ed and observed outcome at various intervals of severity. Dis-
crimination is important while distinguishing the outcome ei-
ther survival or moribund among the admitted patients.
A discriminatory power of 0.90 (AUC) or more is
considered excellent, and it was observed for PRISM
III (0.92) and PELOD-2 (0.94). The closer the ROC
curve area is to 1.0, the better the prediction model [5].
For PRISM III, a Chinese study has shown an area under
ROC curve higher than 0.90 [4]. Other studies have also
showed good performance for PRISM III [7, 4, 12, 21,
25]. PELOD-2 was only validated in one multicenter
cohort study (nine PICUs from France and Belgium)
[14]. Our result for PELOD-2 discrimination is similar
to those published in the previous study. Leteurtre
et al.’s study have shown for PELOD-2 a good discrim-
ination (AUC of 0.94 (95 % CI, 0.93–0.96)). In the same
study, the Hosmer and Lemeshow goodness-of-fit test
showed also a good calibration (χ2=0.931, p=0.317).
PELOD-2 seems to be not calibrated for our popu-
lation. After recalibration, the original equation
logit(mortality)=−6,61+0,47xPELOD−2 is converted in-
to logit(mortality)=−15,17+0,34xPELOD−2. The coeffi-
cients allowing calculation of mortality risk are given by
Probabilityof death ¼ 11þexp −logit mortalityð Þ½ ð Þ.
Table 3 Calibration of the PRISM III and PELOD-2 scores
Quintiles of risk (%) Observed Expected
Survival Death Survival Death
PRISM III 1 117 0 116.56 0.44
2 112 0 111.12 0.88
3 117 0 115.21 1.79
4 94 5 95.51 3.49
5 87 24 86.84 24.16
Total 527 29 525.24 30.76
PELOD-2 1 114 0 113.71 0.29
2 201 0 198.95 2.05
3 88 2 88.01 1.99
4 55 5 57.91 2.09
5 69 22 75.28 15.72
Total 527 29 533.86 22.14
PRISM III Pediatric Risk of Mortality III, PELOD 2 Pediatric Logistic
Organ Dysfunction 2
Table 4 Performance of PRISM
III and PELOD-2 scores Statistical parameter PRISM III PELOD-2
Area under ROC curve (95 %CI) 0.92 (0.86–0.97) 0.94 (0.90–0.98)
Standardized mortality ratio (95 %CI) 0.94 (0.60–1.28) 1.31 (0.83–1.79)
Hosmer–Lemeshow test χ2 3.820 9.576
Hosmer–Lemeshow p value 0.282 0.022
ROC curve receiver operating characteristic curve, PRISM III Pediatric Risk of Mortality III, PELOD 2 Pediatric
Logistic Organ Dysfunction 2
Table 5 Association between PRISM III and PELOD-2 scores and
fatal events
Modela OR (95 % CI) Modelb (95 % CI)
PRISM IIIc 5.2 (3.4–7.9) 6.2 (3.4–11.3)
PELOD-2c 9.3 (5.1–16.8) 10.0 (4.8–20.8)
OR odds ratio, 95 % CI 95 % confidence intervals
a Crude OR
bModel adjusted for age, sex, category of illness on admission, post-
surgical care, mechanical ventilation required, and length of stay in PICU
cOR estimates for increases of 1 unit in PRISM III and PELOD-2
z-scores
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As the prognostic model PELOD-2 demonstrated poor cal-
ibration, its application in the original form in our population
finds no justification. However, it has been shown that when
the discrimination of the model is sufficient, recalibration
using new data improves its performance in a given popula-
tion [9].
The mortality in the present study was 5.2 %. This mortal-
ity was similar to the documented rates at other European
PICUs where the proportion of post-surgical is also higher
[14, 19]. Standardized mortality ratio of the present study
population with PELOD-2 was 1.31 as compared to 0.94 for
the PRISM III score. The SMR reported in this study based on
the PRISM III score was lower than 1.0 and so similar to that
reported from 10 PICUs in Australia and New Zealand [25],
Netherlands [7], and China [4]. A SMR higher than 1.0 was
observed for PELOD-2, but the observed number of deaths
was not significantly different than the expected number of
deaths.
The underprediction of mortality by PELOD-2 compared
to PRISM III could be explained because the predictive mor-
tality models could be population sensitive, so validation stud-
ies are necessary before application in another setting. It is
important to assume that the model’s prediction accuracy is
affected by different case mix between our population and the
original, that is, by a different distribution of outcome and
predictive factors whether included in the model or not [16].
Median duration of stay in PICU (3 days) was similar to
data from most PICUs in developed countries [4, 14]. This
result is explained by the higher surgical post-recovery patient
rates that generally require a short stay in intensive care
setting.
PELOD-2 had an edge over PRISM III having fewer var-
iables making assessment more convenient. Fewer variables
could be economically more acceptable and also make the
uniform training of PICU staff more convenient [1]. The col-
lection of a large amount of information needed to calculate
PRISM III is laborious.
To date, no consensus has been reached as to which score
constitutes the gold standard. We can state that PRISM III and
PELOD-2 offers good discrimination. But, only PRISM III is
accurately calibrated for our population. So, PRISM III is a
tool with better performance in our population. Although the
use of clinical scoring systems to predict death in individuals
is not recommended, they permit categorization into a partic-
ular risk category for clinical trials [15]. In our population, a
low PPV for mortality of a patient actually being in the 5th
quintile was observed, which is 22/91 (24 %) for the PELOD
2 and 24/111 (22 %) for the PRISM III.
In this study, we recognize several limitations. Given the
nature of the study, the quality of recorded data could threaten
the validity of findings. However, variables prospectively col-
lected for PRISM III comprise essential clinical information
for PELOD-2 estimation.
Considering the nature of the present study, comparison of
different scores, the exclusion criteria defined could be not
consensual. In PRISM III, patients staying in PICU <2 h and
those admitted in continuous cardiopulmonary resuscitation
who do not achieved stable vital signs for ≥2 h were excluded
[20]. The PEDOD-2 publication does not exclude patients due
to too short survival time after admission to PICU, and so the
score does not require a 24-h assessment period [14]. In other
comparative score performance studies, death within the first
8 and 10 h of PICU admission was an exclusion criteria [23,
27]. This time, selection could change the score prediction and
introduce lead–time bias. Nonetheless, short time survival in
PICU could lead a death diagnosis role of score rather than
predicting it. Moreover, using this 8-h period as an exclusion
criteria, we decrease the possibility of length–time bias. The
score will be more able to identify patients with worse condi-
tion and early event than those with less severe condition. The
study was conducted in a single center with experience in
pediatric intensive care management and may not be represen-
tative of the Portuguese PICU population. However, the mul-
tidisciplinary character of the unit and big geographical area
that it serves makes this limitation less possible.
It is important to stress that the recalibrated risk prediction
function for both scores has not been validated in an indepen-
dent cohort. PELOD-2 has only been validated in the
bootstrapped original derivation patient set, and so it may have
been overfit to our population. Future thoughts could include
the extension of the study in the same and other Portuguese
PICUs, so that potential multicentre higher population studies
could offer an even better assessment of PRISM III and
PELOD-2 performance and the establishment of a national
standard.
In conclusion, this study shows that PRISM III had good
discrimination and calibration in our pediatric population that
required intensive critical care. After sample adjustment, the
recalibrated PELOD-2 score seems to be credible in clinical
practice and may provide useful information to physicians.
Through this recalibration in our population, it is important
to keep in mind that PELOD-2 does not demonstrate good
calibration in this small Portuguese population.
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